106 related articles for article (PubMed ID: 20149763)
21. LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer.
Sani SN; Zhou W; Ismail BB; Zhang Y; Chen Z; Zhang B; Bao C; Zhang H; Wang X
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831528
[TBL] [Abstract][Full Text] [Related]
22. Analysis of a Broad Range of Carbonyl Metabolites in Exhaled Breath by UHPLC-MS.
Xie Z; Morris JD; Mattingly SJ; Sutaria SR; Huang J; Nantz MH; Fu XA
Anal Chem; 2023 Mar; 95(9):4344-4352. PubMed ID: 36815760
[TBL] [Abstract][Full Text] [Related]
23. Smelling the Disease: Diagnostic Potential of Breath Analysis.
Sharma A; Kumar R; Varadwaj P
Mol Diagn Ther; 2023 May; 27(3):321-347. PubMed ID: 36729362
[TBL] [Abstract][Full Text] [Related]
24. Detection of respiratory inflammation biomarkers in non-processed exhaled breath condensate samples using reduced graphene oxide.
Gholizadeh A; Black K; Kipen H; Laumbach R; Gow A; Weisel C; Javanmard M
RSC Adv; 2022 Dec; 12(55):35627-35638. PubMed ID: 36545081
[TBL] [Abstract][Full Text] [Related]
25. The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?
Keogh RJ; Riches JC
Curr Oncol; 2022 Sep; 29(10):7355-7378. PubMed ID: 36290855
[TBL] [Abstract][Full Text] [Related]
26. In Vivo Detection of Tetrodotoxin in
Meng H; Jiang S; Zhang Y; Hu Y; Liu Y
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144854
[TBL] [Abstract][Full Text] [Related]
27. Exhaled Aldehydes as Biomarkers for Lung Diseases: A Narrative Review.
Floss MA; Fink T; Maurer F; Volk T; Kreuer S; Müller-Wirtz LM
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014494
[TBL] [Abstract][Full Text] [Related]
28. Volatolomics in healthcare and its advanced detection technology.
Hu W; Wu W; Jian Y; Haick H; Zhang G; Qian Y; Yuan M; Yao M
Nano Res; 2022; 15(9):8185-8213. PubMed ID: 35789633
[TBL] [Abstract][Full Text] [Related]
29. Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer-A Review.
Sutaria SR; Gori SS; Morris JD; Xie Z; Fu XA; Nantz MH
Metabolites; 2022 Jun; 12(6):. PubMed ID: 35736492
[TBL] [Abstract][Full Text] [Related]
30. Physiological and metabolic effects of healthy female aging on exhaled breath biomarkers.
Sukul P; Grzegorzewski S; Broderius C; Trefz P; Mittlmeier T; Fischer DC; Miekisch W; Schubert JK
iScience; 2022 Feb; 25(2):103739. PubMed ID: 35141500
[TBL] [Abstract][Full Text] [Related]
31. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases.
Murgia A; Ahmed Y; Sweeney K; Nicholson-Scott L; Arthur K; Allsworth M; Boyle B; Gandelman O; Smolinska A; Ferrandino G
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829792
[TBL] [Abstract][Full Text] [Related]
32. Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS.
Sun Y; Tang H; Wang Y
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684729
[TBL] [Abstract][Full Text] [Related]
33. Mass Spectrometry-Based Human Breath Analysis: Towards COVID-19 Diagnosis and Research.
Yuan ZC; Hu B
J Anal Test; 2021; 5(4):287-297. PubMed ID: 34422436
[TBL] [Abstract][Full Text] [Related]
34. Quantification of Volatile Aldehydes Deriving from In Vitro Lipid Peroxidation in the Breath of Ventilated Patients.
Müller-Wirtz LM; Kiefer D; Ruffing S; Brausch T; Hüppe T; Sessler DI; Volk T; Fink T; Kreuer S; Maurer F
Molecules; 2021 May; 26(11):. PubMed ID: 34064214
[TBL] [Abstract][Full Text] [Related]
35. Breath-Based Diagnosis of Infectious Diseases: A Review of the Current Landscape.
Ghosh C; Leon A; Koshy S; Aloum O; Al-Jabawi Y; Ismail N; Weiss ZF; Koo S
Clin Lab Med; 2021 Jun; 41(2):185-202. PubMed ID: 34020759
[TBL] [Abstract][Full Text] [Related]
36. Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD.
Ratiu IA; Ligor T; Bocos-Bintintan V; Mayhew CA; Buszewski B
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374433
[TBL] [Abstract][Full Text] [Related]
37. 4-Hydroxy-2-nonenal, a lipid peroxidation product, as a biomarker in diabetes and its complications: challenges and opportunities.
Dham D; Roy B; Gowda A; Pan G; Sridhar A; Zeng X; Thandavarayan RA; Palaniyandi SS
Free Radic Res; 2021 May; 55(5):547-561. PubMed ID: 33336611
[TBL] [Abstract][Full Text] [Related]
38. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study.
Zhang Y; Guo L; Qiu Z; Lv Y; Chen G; Li E
J Clin Lab Anal; 2020 Dec; 34(12):e23526. PubMed ID: 33150682
[TBL] [Abstract][Full Text] [Related]
39. Target Analysis of Volatile Organic Compounds in Exhaled Breath for Lung Cancer Discrimination from Other Pulmonary Diseases and Healthy Persons.
Koureas M; Kirgou P; Amoutzias G; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
Metabolites; 2020 Aug; 10(8):. PubMed ID: 32756521
[TBL] [Abstract][Full Text] [Related]
40. Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
Tanaka M; Hsuan C; Oeki M; Shen W; Goda A; Tahara Y; Onodera T; Sanematsu K; Rikitake T; Oki E; Ninomiya Y; Kurebayashi R; Sonoda H; Maehara Y; Toko K; Matsui T
PLoS One; 2020; 15(6):e0235442. PubMed ID: 32598404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
